Authors: Kemper, CA Witt, MD Keiser, PH Dube, MP Forthal, DN Leibowitz, M Smith, DS Rigby, A Hellmann, NS Lie, YS Leedom, J Richman, D McCutchan, JA Haubrich, R

Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615

Authors: Brown, AJL Precious, HM Whitcomb, JM Wong, JK Quigg, M Huang, W Daar, ES D'Aquila, RT Keiser, PH Connick, E Hellmann, NS Petropoulos, CJ Richman, DD Little, SJ

Citation: Ajl. Brown et al., Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites, J VIROLOGY, 74(22), 2000, pp. 10269-10273

Authors: Little, SJ Daar, ES D'Aquila, RT Keiser, PH Connick, E Whitcomb, JM Hellmann, NS Petropoulos, CJ Sutton, L Pitt, JA Rosenberg, ES Koup, RA Walker, BD Richman, DD

Citation: Sj. Little et al., Reduced antiretroviral drug susceptibility among patients with primary HIVinfection, J AM MED A, 282(12), 1999, pp. 1142-1149

Authors: Douek, DC McFarland, RD Keiser, PH Gage, EA Massey, JM Haynes, BF Polis, MA Haase, AT Feinberg, MB Sullivan, JL Jamieson, BD Zack, JA Picker, LJ Koup, RA

Citation: Dc. Douek et al., Changes in thymic function with age and during the treatment of HIV infection, NATURE, 396(6712), 1998, pp. 690-695